Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus Test service to meet the ...

The global flow cytometry market is projected to grow at a CAGR of nearly 9% over the next several years, driven by rising cases of cancer, HIV/AIDS, hematological disorders, and other chronic ...

At ELRIG 2025 in Stevenage, AstraZeneca’s Global Leader for Flow Cytometry, Dr Raffaello Cimbro, outlined how imaging flow cytometry has evolved from a specialist tool into a cornerstone technology ...

TD2 Oncology delivers fully integrated preclinical, regulatory, and clinical services for cancer drug development. In response to advances in In Vivo CAR-T engineering, TD2 Oncology launches flow ...

Detailed price information for Aptose Biosciences Inc (APTOF) from The Globe and Mail including charting and trades.

Despite advancements in the treatment of acute lymphoblastic leukemia (ALL), survival rates vary greatly based on factors such as cancer subtype and geographical location. The use of diagnostic tools ...

One limitation holding back the development of new therapies for food allergies is that many commonly used research tools are outdated and often impractical. Research has been hindered by several ...

How do we “name” a cell and assign its identity? How do we know that we are all talking about the same cells? How do we agree on what it takes to confidently correlate previous with current research ...

The transition from preclinical development to clinical trials is a critical, yet high-risk stage in drug development, with approximately 89% of drugs failing to progress through all phases of ...